Papers - TERAKURA Seitaro
-
Impact of graft-versus-host disease on outcomes after unrelated cord blood transplantation. Reviewed
Kanda J, Morishima Y, Terakura S, Wake A, Uchida N, Takahashi S, Ono Y, Onishi Y, Kanamori H, Aotsuka N, Ozawa Y, Ogawa H, Sakura T, Ohashi K, Ichinohe T, Kato K, Atsuta Y, Teshima T, Murata M.
Leukemia. 2016.11
-
Programmed Death-Ligand 1 on Antigen-presenting Cells Facilitates the Induction of Antigen-specific Cytotoxic T Lymphocytes: Application to Adoptive T-Cell Immunotherapy. Reviewed
Goto T, Nishida T, Takagi E, Miyao K, Koyama D, Sakemura R, Hanajiri R, Watanabe K, Imahashi N, Terakura S, Murata M, Kiyoi H.
J Immunother. 2016.10
-
A Tet-On Inducible System for Controlling CD19-Chimeric Antigen Receptor Expression upon Drug Administration. Reviewed
Sakemura R, Terakura S, Watanabe K, Julamanee J, Takagi E, Miyao K, Koyama D, Goto T, Hanajiri R, Nishida T, Murata M, Kiyoi H.
Cancer Immunol Res. 2016.8
-
Integration of humoral and cellular HLA-specific immune responses in cord blood allograft rejection. Reviewed
Hanajiri R, Murata M, Sugimoto K, Murase M, Sakemura R, Goto T, Watanabe K, Imahashi N, Terakura S, Ohashi H, Akatsuka Y, Kurahashi S, Miyamura K, Kiyoi H, Nishida T, Naoe T.
Bone Marrow Transplant. Vol. 50 ( 9 ) page： 1187-1194 2015.7
-
Cutaneous macrophage infiltration in acute GvHD. Reviewed
Terakura S, Martin PJ, Shulman HM, Storer BE.
Bone Marrow Transplant. Vol. 50 ( 8 ) page： 1135-1137 2015.5
-
Chimerism status after unrelated donor bone marrow transplantation with fludarabine-melphalan conditioning is affected by the melphalan dose and is predictive of relapse. Reviewed
Imahashi N, Ohashi H, Terakura S, Miyao K, Sakemura R, Kato T, Sawa M, Yokohata E, Kurahashi S, Ozawa Y, Nishida T, Kiyoi H, Watamoto K, Kohno A, Kasai M, Kato C, Iida H, Naoe T, Miyamura K, Murata M; Nagoya Blood and Marrow Transplantation Group.
Annals of Hematology Vol. 94 ( 7 ) page： 1139-1148 2015.2
-
Simple and efficient generation of virus-specific T cells for adoptive therapy using anti-4-1BB antibody. Reviewed
Imahashi N, Nishida T, Goto T, Terakura S, Watanabe K, Hanajiri R, Sakemura R, Imai M, Kiyoi H, Naoe T, Murata M.
J Immunother Vol. 38 ( 2 ) page： 62-70 2015.2
-
Comparison of outcomes of 8/8 and 7/8 allele-matched unrelated BMT and single unit CBT in adults with acute leukemia Reviewed
Terakura S, Atsuta Y, Tsukada N, Kobayashi T, Tanaka M, Kanda J, Najima Y, Fukuda T, Uchida N, Takahashi S, Nagamura-Inoue T, Morishima Y, Miyamura K; Japan Society for Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant. 2015
-
Target antigen density governs the efficacy of anti-CD20-CD28-CD3 ζ chimeric antigen receptor-modified effector CD8+ T cells. Reviewed
Watanabe K, Terakura S, Martens AC, van Meerten T, Uchiyama S, Imai M, Sakemura R, Goto T, Hanajiri R, Imahashi N, Shimada K, Tomita A, Kiyoi H, Nishida T, Naoe T, Murata M.
The Journal of Immunology Vol. 194 ( 3 ) page： 911-920 2014.12
-
Comparison of cord blood transplantation with unrelated bone marrow transplantation in patients older than fifty years. Reviewed
Tanaka M, Miyamura K, Terakura S, Imai K, Uchida N, Ago H, Sakura T, Eto T, Ohashi K, Fukuda T, Taniguchi S, Mori S, Nagamura-Inoue T, Atsuta Y, Okamoto S.
Biol Blood Marrow Transplant. Vol. 21 ( 3 ) page： 517-525 2014.12
-
Dexamethasone palmitate ameliorates macrophages-rich graft-versus-host disease by inhibiting macrophage functions. Reviewed
Nishiwaki S, Nakayama T, Murata M, Nishida T, Terakura S, Saito S, Kato T, Mizuno H, Imahashi N, Seto A, Ozawa Y, Miyamura K, Ito M, Takeshita K, Kato H, Toyokuni S, Nagao K, Ueda R, Naoe T.
PLoS One 2014.5
-
Successful unrelated cord blood transplantation for adult acquired aplastic anemia using reduced intensity conditioning without ATG. Reviewed
Terakura S, Nishida T, Inamoto Y, Ohashi H, Naoe T, Murata M.
Immunol Lett. Vol. 160 ( 1 ) page： 99-101 2014.1
-
Unrelated cord blood transplantation vs related transplantation with HLA 1-antigen mismatch in the graft-versus-host direction. Reviewed
Kanda J, Ichinohe T, Kato S, Uchida N, Terakura S, Fukuda T, Hidaka M, Ueda Y, Kondo T, Taniguchi S, Takahashi S, Nagamura-Inoue T, Tanaka J, Atsuta Y, Miyamura K, Kanda Y; Donor/Source Working Group and HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.
Leukemia Vol. 27 ( 2 ) page： 286-294 2012.7
-
Phase II study of dose-modified busulfan by real-time targeting in allogeneic hematopoietic stem cell transplantation for myeloid malignancy. Reviewed
Kuwatsuka Y, Kohno A, Terakura S, Saito S, Shimada K, Yasuda T, Inamoto Y, Miyamura K, Sawa M, Murata M, Karasuno T, Taniguchi S, Nagafuji K, Atsuta Y, Suzuki R, Fukumoto M, Naoe T, Morishita Y; Nagoya Blood and Marrow Transplantation Group.
Cancer Science Vol. 103 ( 9 ) page： 1688-1694 2012.7
-
Generation of CD19-chimeric antigen receptor modified CD8+ T cells derived from virus-specific central memory T cells. Reviewed
Terakura S, Yamamoto TN, Gardner RA, Turtle CJ, Jensen MC, Riddell SR.
Blood Vol. 119 ( 1 ) page： 72-82 2011.10
-
A prospective dose-finding trial using a modified continual reassessment method for optimization of fludarabine plus melphalan conditioning for marrow transplantation from unrelated donors in patients with hematopoietic malignancies. Reviewed
Terakura S, Atsuta Y, Sawa M, Ohashi H, Kato T, Nishiwaki S, Imahashi N, Yasuda T, Murata M, Miyamura K, Suzuki R, Naoe T, Ito T, Morishita Y; Nagoya Blood and Marrow Transplantation Group.
Annals of Oncology Vol. 22 ( 8 ) page： 1865-1871 2011.2
-
CTL clones isolated from an HLA-Cw-mismatched bone marrow transplant recipient with acute graft-versus-host disease. Reviewed
Sugimoto K, Murata M, Terakura S, Naoe T.
The Journal of Immunology Vol. 183 ( 9 ) page： 5991-5998 2009.10
-
Impact of macrophage infiltration of skin lesions on survival after allogeneic stem cell transplantation: a clue to refractory graft-versus-host disease. Reviewed
Nishiwaki S, Terakura S, Ito M, Goto T, Seto A, Watanabe K, Yanagisawa M, Imahashi N, Tsukamoto S, Shimba M, Ozawa Y, Miyamura K.
Blood Vol. 114 ( 14 ) page： 3113-3116 2009.7
-
A single minor histocompatibility antigen encoded by UGT2B17 and presented by human leukocyte antigen-A*2902 and -B*4403. Reviewed
Terakura S, Murata M, Warren EH, Sette A, Sidney J, Naoe T, Riddell SR.
Transplantation. Vol. 83 ( 9 ) page： 1242-1248 2007.5
-
Hematopoietic engraftment in recipients of unrelated donor umbilical cord blood is affected by the CD34+ and CD8+ cell doses. Reviewed
Terakura S, Azuma E, Murata M, Kumamoto T, Hirayama M, Atsuta Y, Kodera Y, Yazaki M, Naoe T, Kato K.
Biol Blood Marrow Transplant. Vol. 13 ( 7 ) page： 822-830 2007.4